PatternsRadar
Sign in

SUPRIYASupriya Lifescience Limited

NSEASM Stage I
620.15INR-4.85 (-0.78%)Close · 20 Nov 2026
6 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹4,991 CrMarket cap
28.2P/E (TTM)
53.7%Delivery

Filings & corporate actions

20 results filed
CSV
Next results · Q3 FY27
Expected 21 Jan 2027 – 15 Feb 2027
Estimate: filed 21–46 days after quarter end, last 5 times
Dividend
₹1.00 per share · last 4 Sept 2026
2026
  • 6 NovresultsResults · Q2 FY27 · standalone-20.0%NSE
  • 14 OctshareholdingShareholding · 30 Sept 2026-0.9%NSE
  • 4 SeptdividendDividend · ₹1.00 per share+1.2%
  • 13 AugresultsResults · Q1 FY27 · standalone-2.7%NSE
  • 18 JulshareholdingShareholding · 30 Jun 2026+1.0%NSE
  • 27 MayresultsResults · Q4 FY26 · standalone+20.0%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026+1.6%NSE
  • 9 FebresultsResults · Q3 FY26 · standalone-0.1%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-2.2%NSE

Reaction to results · all yearsrose on day 0 in 6 of 20 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY276 Nov 2026-20.0%-27.3%—13.4×
Q1 FY2713 Aug 2026-2.7%-1.0%+10.8%6.6×
Q4 FY2627 May 2026+20.0%+17.4%+20.3%24.9×
Q3 FY269 Feb 2026-0.1%-2.7%-13.3%2.3×
Q2 FY2612 Nov 2025+3.2%+1.4%-2.0%4.1×
Q1 FY2613 Aug 2025-0.9%+5.1%-1.8%4.4×
Q4 FY2527 May 2025-1.0%-4.1%-8.1%2.3×
Q3 FY2524 Jan 2025-5.3%+2.9%-8.7%1.9×
Q2 FY2528 Oct 2024+8.8%+16.4%+36.6%4.6×
Q1 FY2510 Aug 2024+13.9%+19.0%+35.6%16.9×
Q4 FY2429 May 2024-4.2%-4.2%+6.2%3.3×
Q3 FY248 Feb 2024+13.0%+19.6%+13.5%23.2×
Q2 FY248 Nov 2023-5.1%-3.0%+7.2%2.7×
Q1 FY244 Aug 2023-0.2%-4.8%-0.8%2.1×
Q4 FY2327 May 2023-1.9%-1.5%-3.2%0.5×
Q3 FY2315 Feb 2023-2.8%+5.5%-1.1%8.2×
Q2 FY2311 Nov 2022-2.8%-2.6%-4.1%2.2×
Q1 FY2313 Aug 2022+2.1%+0.5%-1.5%2.5×
Q4 FY2221 May 2022-3.3%-4.7%-21.1%1.1×
Q3 FY2221 Jan 2022-1.3%-1.5%-18.2%—
Average+0.5%+1.5%+2.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+3.2%
Profit YoY-42.0%
Interest cost YoY-3.1%
Revenue QoQ+8.7%
Profit QoQ+21.7%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+18.6%+19.2%+14.5%———
Profit+6.1%+21.0%+8.5%———

Key data

Open616.20
Day range610.20 – 624.35
52-week range545.50 – 1,085.00
From 52w high-42.8%
RSI (14)25.6
ATR (14)32.96
Volume1.32L
Avg volume (20D)4.70L
Rel volume0.28×
Volatility (1Y)53.0%
Turnover₹8.2Cr
Traded value (NSE)₹8.2Cr
VWAP615.71
SMA 50 / 200836.18 / 783.06
Price band20%

Delivery percentage

Latest · 20 Nov 202653.7%
20-day avg45.2%
1-year avg46.3%
Percentile (own history)83rd
Range10.9–80.4%
Sessions1,212

Over the last 20 sessions SUPRIYA settled 45.2% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 46.3%. The latest session ranks higher than 83% of the 1,212 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.16%
Dividend, trailing 12M₹1.00
Paid every year for5 yr
Shareholders78.6K · -4.3% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy728 days ago

Performance returns

1D1W1M3M6M1Y
Price-0.78%-1.89%-25.84%-23.60%-15.50%-21.47%

Valuation

Market cap₹4,991 Cr
Market cap (NSE)₹4,991 Cr
Free-float cap₹1,582 Cr
P/E (TTM)28.2
P/E (NSE)28.4
EPS (TTM)22.02
P/B4.0
Net margin (TTM)20.2%
Other income / PBT4.6%
ROE15.2%
Debt / equity0.00
Shares outstanding8.05Cr
Listed28 Dec 2021

Ownership

Promoter68.30%
Promoter Δ QoQ0.00 pp
Public31.70%
FII6.44%
DII5.47%
Pledged0.00%

Quarterly results · standalone

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)206.4276.5189.7206.3
YoY chg+11.2%+50.2%+30.8%+3.2%
Net profit (₹ Cr)49.774.224.029.3
YoY chg+6.2%+47.3%-30.9%-42.0%
Net margin24.1%26.8%12.7%14.2%
EPS6.179.222.993.63

Shareholding over time

By quarter

30 Sept 2026 · promoter 68.30% · public 31.70%
23 Dec 2021: promoter 68.24%31 Dec 2021: promoter 68.24%31 Mar 2022: promoter 68.24%30 Jun 2022: promoter 68.24%30 Sept 2022: promoter 68.24%31 Dec 2022: promoter 68.24%31 Mar 2023: promoter 68.28%30 Jun 2023: promoter 68.30%30 Sept 2023: promoter 68.30%31 Dec 2023: promoter 68.30%31 Mar 2024: promoter 68.30%30 Jun 2024: promoter 68.30%30 Sept 2024: promoter 68.30%31 Dec 2024: promoter 68.30%31 Mar 2025: promoter 68.30%30 Jun 2025: promoter 68.30%30 Sept 2025: promoter 68.30%31 Dec 2025: promoter 68.30%31 Mar 2026: promoter 68.30%30 Jun 2026: promoter 68.30%30 Sept 2026: promoter 68.30%
2021-122026-09
  • Promoter
  • Public and others
Promoter
68.30%
Public
31.70%
Promoter change
0.00 pp
Filed
14 Oct 2026
FII
6.44%
DII
5.47%
Promoter pledged
0.00%

Who the public is

Mutual funds
1.28%

-0.01 pp QoQ

Insurance
2.37%

-0.03 pp QoQ

FPI
6.45%

+0.27 pp QoQ

Retail ≤ ₹2L
14.18%

-0.56 pp QoQ

HNI > ₹2L
1.25%

+0.01 pp QoQ

NRI
1.04%

-0.07 pp QoQ

Bodies corporate
2.53%

+0.36 pp QoQ

Shareholders
78,561

-4.3% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Satish Waman WaghPromoter · Individual67.64%
COHESION MK BEST IDEAS SUB-TRUSTFPI3.17%
ADITYA BIRLA SUN LIFE INSURANCE COMPANY LIMITEDInsurance2.16%
Smita Satish WaghPromoter · Individual0.40%
Saloni Satish WaghPromoter · Individual0.13%
Shivani Satish WaghPromoter · Individual0.13%
Arun Waman WaghPromoter · Individual0.00%
Satish Waman Wagh Partner representing SupriyaPharmaceuticalsPromoter · Other0.00%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 1 Sept 2022 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹1.00₹1.00
FY2025-261₹1.00₹1.00
FY2024-251₹0.80₹0.80
FY2023-241₹0.60₹0.60
FY2022-231₹0.60₹0.60
Ex-dateRecord dateDeclaredAdjusted
4 Sept 2026—₹1.00₹1.00
4 Sept 2025—₹1.00₹1.00
20 Sept 2024—₹0.80₹0.80
15 Sept 2023—₹0.60₹0.60
1 Sept 2022—₹0.60₹0.60

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
3.6 years ago
Disclosures on record
8
6 open-market of the newest 8
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
3 Apr 2023Satish Waman WaghPromoterBuy13.0K₹24.7L190.225.44Cr → 5.44Cr67.64%+0.02 pp7(2)told 3 Apr 2023
31 Mar 2023Satish Waman WaghPromoterBuy14.0K₹24.9L177.795.44Cr → 5.44Cr67.63%+0.02 pp7(2)told 31 Mar 2023
6 Mar 2023Satish Waman WaghPromoterBuy2.0K₹4.1L203.695.44Cr → 5.44Cr67.61%+0.00 pp7(2)told 6 Mar 2023
6 Mar 2023Satish Waman WaghPromoterBuy8.0K₹16.3L203.695.44Cr → 5.44Cr67.61%+0.01 pp7(2)told 6 Mar 2023
2 Mar 2023Satish Waman WaghPromoterBuy8.0K₹15.8L198.065.44Cr → 5.44Cr67.59%+0.01 pp7(2)told 1 Mar 2023
2 Mar 2023Satish Waman WaghPromoterBuy2.0K₹4.0L198.065.44Cr → 5.44Cr67.59%+0.00 pp7(2)told 1 Mar 2023

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 22 Nov 2024

CSV
12 of 35 deals
By year
DateDealClientQuantityPriceValue
22 Nov 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP5.85L785.02₹45.9Cr
22 Nov 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP5.85L784.79₹45.9Cr
12 Aug 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP6.58L488.61₹32.2Cr
12 Aug 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP6.58L488.59₹32.2Cr
8 Feb 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP6.28L342.32₹21.5Cr
8 Feb 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP6.28L342.21₹21.5Cr
26 Dec 2023Sell · bulkGRAVITON RESEARCH CAPITAL LLP4.57L312.40₹14.3Cr
26 Dec 2023Buy · bulkGRAVITON RESEARCH CAPITAL LLP4.57L312.26₹14.3Cr
12 May 2023Sell · bulkGRAVITON RESEARCH CAPITAL LLP4.03L248.48₹10.0Cr
12 May 2023Buy · bulkGRAVITON RESEARCH CAPITAL LLP4.03L248.38₹10.0Cr
27 Mar 2023Sell · bulkDOVETAIL INDIA FUND CLASS 6 SHARES5.47L177.08₹9.7Cr
24 Jan 2022Sell · bulkGRAVITON RESEARCH CAPITAL LLP4.88L460.52₹22.5Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • Short-term ASM · Stage I — Short-term Additional Surveillance Measure: a sharp move over a few days; a higher margin applies while it lasts.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

Standalone
₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations140.1158.2160.6166.1185.6184.1145.1199.8206.4276.5189.7206.3
Other income3.12.22.22.52.13.02.72.72.63.52.62.3
Total income143.1160.4162.9168.6187.7187.1147.7202.6209.1280.0192.4208.6
Total expenses103.0107.2103.1106.6125.2123.0100.3134.2141.7187.9151.6170.8
└ Finance costs0.50.60.30.40.50.40.50.40.50.50.40.5
└ Depreciation4.03.94.74.75.06.16.56.66.88.58.99.5
Profit before tax40.153.259.862.162.664.147.468.366.992.140.837.8
Tax expense10.316.215.115.915.813.712.617.917.217.916.78.5
Net profit29.836.944.646.146.850.434.850.449.774.224.029.3
EPS3.704.595.545.715.826.294.326.276.179.222.993.63
Net margin21.27%23.35%27.79%27.78%25.20%27.37%23.98%25.23%24.06%26.84%12.67%14.18%
PBT margin28.63%33.62%37.21%37.36%33.71%34.80%32.68%34.19%32.42%33.32%21.50%18.31%
Tax rate25.72%30.55%25.31%25.64%25.24%21.35%26.62%26.19%25.77%19.43%41.06%22.57%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 6 Nov 2026.

Balance sheet & cash flow · half-yearly

Standalone
₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets820.3843.0921.21,012.41,112.31,203.01,357.11,421.7
Current assets464.9410.9397.8413.4437.0505.1532.3677.2
└ Cash & equivalents85.3104.068.377.576.199.337.541.0
└ Other bank balances72.311.86.66.83.14.041.334.9
└ Current investments0.00.00.00.00.00.00.0106.6
└ Trade receivables84.784.8111.7105.7134.4155.1219.4125.6
└ Inventories115.898.885.2108.0118.3142.8159.6265.2
Total equity699.5753.2815.4905.9996.81,081.81,197.71,242.6
└ Attributable to owners699.5753.2815.4905.9996.81,081.81,197.71,242.6
└ Share capital16.116.116.116.116.116.116.116.1
Borrowings16.60.10.00.00.00.00.00.0
└ Current16.60.10.00.00.00.00.00.0
└ Non-current0.00.00.00.00.00.00.00.0
Trade payables64.255.259.662.40.076.4110.8107.1
Current liabilities95.865.676.975.482.282.9121.0130.4
Total liabilities120.889.9105.9106.5115.6121.2159.4179.1
Net debt(141.0)(115.7)(75.0)(84.3)(79.2)(103.2)(78.9)(182.6)
Debt / equity0.020.000.000.000.000.000.000.00
Current ratio4.856.265.175.485.326.094.405.19

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow66.256.0113.392.2164.755.6185.860.9
└ Capex(108.4)(53.0)(145.7)(75.8)(162.4)(42.2)(152.2)0.0
Free cash flow(42.2)2.9(32.3)16.32.313.333.560.9
Investing cash flow(133.1)(80.0)(173.6)(82.5)(152.2)(30.4)(176.2)(38.8)
Financing cash flow(3.4)(17.7)(22.4)(0.3)(8.2)(1.1)(9.9)(8.5)
└ Dividends paid(4.8)0.0(4.8)0.0(6.4)0.0(8.0)(8.0)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(70.3)(41.8)(82.6)9.44.224.1(0.3)13.5

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SUPRIYA at a glance

  • SUPRIYA closed at ₹620.15 on 20 Nov 2026, -0.78% on the day, -21.5% over one year, 42.8% below its 52-week high of ₹1,085.
  • Delivery was 53.7% of traded quantity on 20 Nov 2026, the 83rd percentile of its own 1,212 sessions with a reading (20-session average 45.2%, 1-year average 46.3%).
  • Market capitalisation is ₹4,991 crore at a trailing P/E of 28.2 (trailing EPS ₹22.02).
  • Q2 FY27 results (standalone, filed 6 Nov 2026): revenue ₹206 crore (+3.2% year on year), net profit ₹29 crore (-42.0%); the price moved -20.0% on the first session after.
  • Promoters held 68.30% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 21 Jan 2027 and 15 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE07RO01027
SeriesEQ
Listed28 Dec 2021
IPO price274.00 · band Rs.265 to Rs.274
IPO listing28 Dec 2021
NSE market cap · 17 Nov 2026₹4,995 Cr
Free-float market cap (NSE)₹1,584 Cr
Shares outstanding (NSE)8.05Cr
History from28 Dec 2021
Sessions1,215
Turnover rank#566

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.